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Devices implanted into the body become encapsulated due to a foreign body reaction. In the central
nervous system (CNS), this can lead to loss of functionality in electrodes used to treat disorders. Around
CNS implants, glial cells are activated, undergo gliosis and ultimately encapsulate the electrodes. The
primary cause of this reaction is unknown. Here we show that the mechanical mismatch between
nervous tissue and electrodes activates glial cells. Both primary rat microglial cells and astrocytes
responded to increasing the contact stiffness from physiological values (G0 w 100 Pa) to shear moduli
G0  10 kPa by changes in morphology and upregulation of inﬂammatory genes and proteins. Upon
implantation of composite foreign bodies into rat brains, foreign body reactions were signiﬁcantly
enhanced around their stiff portions in vivo. Our results indicate that CNS glial cells respond to me-
chanical cues, and suggest that adapting the surface stiffness of neural implants to that of nervous tissue
could minimize adverse reactions and improve biocompatibility.
 2014 The Authors. Published by Elsevier Ltd. All rights reserved.1. Introduction
Implantation of medical devices leads to a local foreign body
reaction (FBR), which can cause local and systemic problems. In this
process, implants are encapsulated by reactive tissue, which in the
central nervous system (CNS) consists mainly of activated glial cells
e microglia and astrocytes e surrounded by extracellular matrix.
Glial cells make up about half of the cell population in the brain.
Microglial cells are the resident immune cells of the CNS and the
ﬁrst line of defense, whereas astrocytes, which assume a multitude
of functions, are the most abundant glial cells in the brain. The
reactive process, which starts with the activation of glial cells, can
damage local neurons, and the subsequent dendritic retraction andnse (http://creativecommons.
Development and Neurosci-
UK. Tel.: þ44 1223 333761;
rsity of California, LA, USA.
Published by Elsevier Ltd. All righneuronal death may contribute to a gradual decline in the function
of implanted electrodes [1e3].
Glial cell activation is characterized by hypertrophy (increase in
volume and processes), proliferation (increase in cell number), and
inﬂammatory reactions [4,5]. After subsidence of an acute injury
response, implanted foreign bodies become chronically surrounded
by activated microglial cells [6], which release proinﬂammatory
and immunoregulatory substances [7], followed by a layer of
reactive astrocytes [8] with an increased production of intermedi-
ate ﬁlaments (particularly glial ﬁbrillary acidic protein, GFAP) [4,5].
The resulting glial scar may have a toxic effect on local neurons and
acts as a physical barrier around the implant [6], thus insulating it
from the remaining neurons and, in case of an electrode, detri-
mentally increasing its impedance [9].
The universal occurrence of the FBR is not well correlated with
the chemical nature of the implant [10], which is generally selected
to be inert. This poses the question about the trigger of an FBR.
Importantly, CNS cells not only respond to chemical but also to
mechanical signals (i.e., they are mechanosensitive). For example,
most neuronal and glial cell types adapt their morphology and
cytoskeletal composition to the stiffness of their surrounding
in vitro [11e17].ts reserved.
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neural implants are usually orders of magnitude stiffer than the
physiological cell environment. Hence, it seemed possible that local
cells respond to a mismatch of mechanical compliance between
nervous tissue and the implant. To pursue this idea, we exposed
microglia and astrocytes, the main contributors to FBRs in the CNS,
to materials of different stiffness but same chemical properties and
tested their morphological and inﬂammatory responses to these
mechanical signals in vitro and in vivo.
2. Materials and methods
2.1. Cell cultures
Compliant culture substrates were fabricated from polyacrylamide as described
previously [13] and functionalized with poly-D-lysine solution (PDL; Sigma) (see
Supporting information for details and Fig. S5 for control measurements of rheo-
logical properties and PDL coating). All animal experiments were conducted in
accordance with the United Kingdom Animals (Scientiﬁc Procedure) Act of 1986 and
institutional guidelines. Cell cultureswere prepared from neonatal SpragueeDawley
rat cerebral cortices as previously described [18]. 50,000 astrocytes or 100,000
microglia suspended in 300 ml culture mediumwere added onto each gel. All in vitro
experiments were done after one day in culture.
2.2. Quantitative morphometry of glial cells
Phase contrast images of cells (72e344 cells per gel in 5e8 ﬁelds of view, 3
cultures per cell type) were taken. According to changes in morphology, four
morphological categories were deﬁned for microglia and ﬁve for astrocytes and
arbitrary scores of 1 (for the round cell shape) to 4 or 5 (for the most spread cell
shape) were assigned to each category [13] (Fig. 1).
2.3. Immunocytochemistry
Cells were ﬁxed in 4% paraformaldehyde (PFA) for 10 min and washed in PBS
three times for 10 min. Cells were then treated with 10% normal goat serum
(Sigma) in PBS containing 0.1% Triton-X100 (Sigma; PBS-TX100) for 1 h. For IL-1b,
the blocking step was performed with normal donkey serum (Stratech). Primary
antibodies (or cocktails of primary antibodies; for details see Supporting
information) were prepared in proper dilutions in PBS-TX100 and added to the
cells. Cells were incubated for 2 h at room temperature, or alternatively overnightFig. 1. Glial cell morphology depends on substrate stiffness. Both primary microglial cells
substrate. (A, D) On compliant substrates mimicking brain tissue elasticity (G0 ¼ 100 Pa) bot
star-like morphologies, resembling their in vivo shape (arrow in D). (B, E) On stiffer substrat
signiﬁcantly more and extended several processes. An activated phenotype was frequently ob
analysis (score according to cell morphology [13]) conﬁrmed that morphological changes in
(Nstiff ¼ 447; Nsoft ¼ 418); Pastrocytes ¼ 2E-39 (Nstiff ¼ 550; Nsoft ¼ 625); ManneWhitney testat 4 C, washed, and incubated with appropriate secondary antibodies. After 1 h
incubation at room temperature, cells were washed and mounted with FluorSave
mounting reagent.
Image stacks were obtained with a confocal laser scanning microscope (Leica
SP2 or Zeiss 510Meta). For Figs. 2 and 3, maximum projections were generated using
ImageJ (NIH). In Fig. 2, gray levels were adjusted with Adobe Photoshop, settings for
the same channels were kept constant for all samples.2.4. Genome-wide proﬁle of gene expression
Total RNAwas extracted using RNeasyMinElute Cleanup Kit (QIAGEN) following
the manufacturer’s protocol. RNA quality and quantity was assessed using an RNA
Pico Chip kit (RNA 6000 Pico Chip Kit, Agilent Technologies); genomic DNA was
removed using the Ambion TURBO DNA-free DNase Treatment (Ambion) kit.
RNase activity was prohibited by implementing 20 Units of SUPERase-In (Ambion),
and RNA quality and quantity evaluated again. Equal RNA quantities were processed
with WT-Ovation Pico RNA Ampliﬁcation System (NuGEN).
Sense-Target cDNA was generated, fragmented, biotinylated and hybridized
onto Affymetrix Rat Gene 1.0 ST microarrays. The hybridized probe arrays were
stained with streptavidin phycoerythrin conjugate and scanned using an Affymetrix
GeneChip 7G scanner. Raw image data were converted to CEL using Affymetrix
GeneChip Operating Software (GCOS). All downstream analysis of microarray data
was performed using GeneSpring GX 11 (Agilent). CEL ﬁles were used for both the
robust multiarray average (RMA) [19] and Probe Logarithmic Intensity Error esti-
mation (PLIER) analyses [20], and expression values on the chip were normalized to
the chip’s 50th percentile. Each independent experiment included three arrays from
three biological replicates. Statistical analysis was performed using a one-sample
Student’s t-test, which was applied to the mean of each normalized value against
the baseline value of 1. Genes regulated differently by more than 1.3-fold from the
control conditionwith a P< 0.05 were considered signiﬁcant. Only genes whichmet
the above criteria using RMA and PLIER were examined and shown in Tables S1, S2,
S8 and S9.
Functional analyses were performed (Tables S3, S4, S10 and S11) using In-
genuity Pathway Analysis (IPA) (Ingenuity Systems Inc., USA; www.ingenuity.com)
to identify the biological functions and diseases that were most signiﬁcant to the
data set (Tables S5, S6, S12 and S13). The signiﬁcance of the association between
the data set and the pathway was measured by two means: (1) A ratio of the
number of molecules from the data set that map to the pathway divided by the
total number of molecules that map to the canonical pathway is displayed and (2)
Fisher’s exact test was used to calculate a P value to determine the probability that
the association between the genes in the data set and the pathway is due to chance(AeC) and astrocytes (DeF) change their morphology in response to the stiffness of the
h cell types showed spherical morphologies. Moreover, astrocytes occasionally showed
es (G0 ¼ 30 kPa and 10 kPa for microglia and astrocytes, respectively), glial cells spread
served on stiff gels (arrowheads in B). Scale bars: 50 mm. (C, F) A quantitative cell shape
microglia and astrocytes cultured on stiff substrates were signiﬁcant (Pmicroglia ¼ 1E-30
). Scale bars: 30 mm.
Fig. 2. Inﬂammatory responses of microglial cells to stiff substrates. (AeF) Fluorescence images of microglia cultured on compliant (AeC) and stiff (DeF) substrates for 1 day and
stained for inﬂammatory mediators TLR4 (A, D) and PPARg (B, E). (C, F) Overlay of PPARg, TLR4, and Hoechst-labeled cell nuclei. Scale bar: 50 mm. (G) Western blots showing
intracellular protein concentrations after 1 day in culture. (H) Quantitative analysis of Western blots revealed that both PPARg and TLR4 levels were signiﬁcantly upregulated on
stiffer substrates (N ¼ 3, P < 0.05, paired two-tailed t-test; mean  S.E.M.).
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2.5. Quantitative real-time PCR (qPCR)
A TaqMan real-time PCR method was applied to conﬁrm changes in expression
proﬁles of a selection of genes in microglia (i.e., LPL, RELA, PPARG, ALCAM, CCR1,
CD9, CD97, CSF2, CSF3, P2RY1, TLR4, SDC4, ANGPT1 and TREM1). A separate set of
RNA was extracted from microglia, puriﬁed and converted to cDNA as describedFig. 3. Inﬂammatory response of astrocytes to stiff substrates. (AeF) Fluorescence imag
stained for inﬂammatory mediators Caspase-1 (A, D) and Interleukin 1b (B, E). (C, F) Overla
Western blots showing intracellular protein concentrations after 1 day in culture. (H) Quantit
levels were signiﬁcantly upregulated on stiffer substrates (N ¼ 3, P < 0.05; paired two-tailabove. Real-time PCR was run using TaqMan primers and reagents (Applied Bio-
systems) and arbitrary units of gene quantities were extracted from Ct values using
the standard curves. Among BACTIN, GAPDH and B2M, BACTIN showed the smallest
variation and was therefore selected as the house-keeping control.
2.6. Western blot analysis
Astrocytes were gently detached using ice-cold EDTA (5 mM in PBS, Sigma), spun
down, resuspended in ice-cold PBS and pelleted again. Astrocytes were lysed usinges of astrocytes cultured on compliant (AeC) and stiff (DeF) substrates for 1 day and
y of Caspase-1, Interleukin 1b, and Hoechst-labeled cell nuclei. Scale bar: 100 mm. (G)
ative analysis of Western blots revealed that both pro-Caspase-1 and pro-Interleukin 1b
ed t-test; mean  S.E.M.).
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mixed with Laemmli sample buffer and incubated for 2 min at 95 C. Microglia were
collected similarly and equalized tow2.25  106 cells. Cells were pelleted and lysed
with 30 ml of ice-cold lysis buffer (Cell Signaling) supplemented with additional
protease inhibitors (Complete Lysis-M kit, Roche) for 30e60 min. Intermittent
vortexing and sonication was performed every 15 min. Laemmli sample buffer
(Biorad) was added to cell lysates and heated to 100 C for 10 min.
Samples were run through 4e20% gradient PAA gels (110V, Pierce) and trans-
ferred to 0.45 mm pore size polyvinylidene ﬂuoride (PVDF) membranes (Fisher
Scientiﬁc). Membranes were blocked in 5% skimmed milk dissolved in Tris buffered
saline-Tween 20 (TBS-T; 20 mM Tris Base, 150 mM NaCl, and 0.1% Tween-20, Sigma)
or 5% bovine serum albumin (BSA) for 60 min. Membranes were blotted for proteins
(antibodies were dissolved in TBS-T containing 1% semi-skimmed milk) followed by
horseradish peroxidase (HRP)-tagged secondary antibody treatment. Immuno-
labeled protein bands were visualized by chemiluminescence (ECL Plus, Amer-
sham) on conventional X-ray ﬁlm (Kodak). In microglial samples, avidin-biotin
ampliﬁcation (Vectastain, Vector labs) was used. Blots were visualized by CCD
camera and UVISoft software (UVITEC Cambridge).
Western blots were quantiﬁed using ImageJ software. Brieﬂy, images were
inverted, boxes of equal size were drawn around the bands of interest, and mean
white values (MWV) measured; background was measured accordingly and sub-
tracted from the band values. The method was conﬁrmed by Gaussian ﬁtting anal-
ysis using Origin. Brieﬂy, plot proﬁles of inverted blots were plotted and ﬁtted to a
Gaussian. Background was subtracted from the base of the curve and the integrated
value of the curve was determined.
2.7. In vivo study
PAA premixes of 30 kPa and 100 Pa gels were polymerized on top of each other
in a 0.2 ml PCR tube, removed, and treated as before. Cylindrical composite gels of
w3mm lengthwere prepared and implanted into brains of 14 SpragueeDawley rats.
After opening the skull, a composite foreign body was inserted into brain tissue
using ﬁne tweezers (Fig. 4). The insertion point was located 1.5 mm lateral to the
midline mid-way between Bregma and Lambda planes. The brain was covered with
the excised bony slab and the skin was sutured. Animals received analgesic in-
jections for the following 2e3 days. 1 or 3 weeks after gel implantation, animals
were overdosed with Euthanal (Merial Animal Health Ltd) and perfused trans-
cardially using PBS followed by 4% PFA. Regions of interest were trimmed from the
brains, post-ﬁxed for 2 h in 4% PFA, immersed in a 25% sucrose solution overnight,
cut along the coronal plane into 16 mm-thick slices using a Leica Cryostat (CM3000,
Leica), and slices stained using immunohistochemistry (see Supporting
information).
Images were taken using a confocal laser scanning microscope and stitched
together using Corel Draw X3 software. The interface between the brain tissue and
different gel types was determined using bright ﬁeld images (Fig. S1). Fluorescence
images were analyzed using Adobe Photoshop CS5 software. To capture local re-
sponses to foreign body stiffness, the edges of the lesion around the stiff and soft gels
were separately found using the magic lasso tool, the border of the mask was
extended to 50 pixels, and average gray values of these selections determined. This
way, protein levels around the stiff and soft parts of the implant in the same animal
were normalized for the contact area of implant and tissue (Fig. 4).
2.8. Statistical analysis
In vitro data was collected in all cases from at least three different cultures.
Origin software (Version 8; OriginLab) was used to analyze the statistical signiﬁ-
cance of the data. KolmogoroveSmirnov tests conﬁrmed a normal distribution of
values before any parametric test was employed.
3. Results
3.1. Cell morphology
In order to examine the putative effect of contact compliance on
glial cells, we cultured primary rat microglia and astrocytes on
polyacrylamide substrates of different compliance but identical
poly-D-lysine surface coating [13] (Fig. 1). Two compliance regimes
were used: shear storage moduli G0 ¼ 100 Pa, resembling physio-
logical brain tissue elasticity [21,22], and 10 or 30 kPa, which is
signiﬁcantly stiffer than brain tissue and at least an order of
magnitude above the substrate stiffness at which astrocytes un-
dergo a transition from a compliant to stiff phenotype [13]. We
studied morphological, gene and protein expression changes as a
function of substrate stiffness after one day in culture.
Microglial cells growing on 100 Pa surfaces mostly showed
spherical morphologies, with some short processes andlamellipodia (Fig. 1A). On stiff substrates (G0 ¼ 30 kPa) microglia
spread more and assumed cell shapes generally seen in cultures on
rigid surfaces (Fig. 1B) [23]. A quantitative analysis [13] showed
signiﬁcant morphological differences (Fig. 1C). Consistent with
previous studies [12,13], astrocytes on compliant gels either had a
rounded shape or a star-like morphology with ﬁne processes, quite
unlike their usual in vitro appearance on rigid substrates, but
resembling their in vivo morphology (Fig. 1D). Astrocytes on stiff
substrates (G0 ¼ 10 kPa) spread signiﬁcantly more and acquired a
polygonal shape as on rigid tissue culture plastic or glass surfaces
(Fig. 1E). Quantitative shape analysis conﬁrmed that also differ-
ences in astrocyte morphologies were signiﬁcant (Fig. 1F). Hence,
both microglia and astrocytes displayed morphological character-
istics of an activated phenotype on stiffer substrates.
3.2. Gene and protein expression in microglia
We then investigated whether glial responses to mechanical
stiffness might also involve the production of molecules that could
trigger an inﬂammatory reaction. We ﬁrst analyzed the transcrip-
tional proﬁle of microglial cells and astrocytes as a function of
substrate compliance using DNA microarrays.
In microglial cells 73 genes were signiﬁcantly upregulated on
stiff substrates compared to compliant ones (Table S1) and 123
genes downregulated (Table S2). A functional gene expression
analysis revealed, amongst others, signiﬁcant increases in the in-
ﬂammatory response (P ¼ 1.9E-06), immune cell trafﬁcking
(P ¼ 9.6E-05), cellular growth and proliferation (P ¼ 7.5E-05), cell-
mediated immune response (P ¼ 2.2E-04), and antigen presenta-
tion (P ¼ 1.1E-04) of microglia grown on stiff substrates (Table S3,
for signiﬁcant decreases see Table S4). In total, 15 pathways related
to different inﬂammatory and pathogenic functions were upregu-
lated on stiff substrates (Table S5), and 8 were attenuated
(Table S6). Individual inﬂammation-related genes that were
signiﬁcantly enhanced in microglia cultured on the stiffer gels and
that are important for FBR include markers of microglia activation
(CD97 and PPARg), receptors mediating microglia activation (TLR4
and TREM1), and receptors involved in adhesion and migration
(CD9 and CD97). The increased expression of these genes was
veriﬁed by qPCR (Table S7); immunocytochemistry and Western
blots conﬁrmed signiﬁcant upregulation of PPARg and TLR4 at the
protein level (Fig. 2).
3.3. Gene and protein expression in astrocytes
Comparing gene expression in astrocytes that were grown on
stiff substrates (G0 ¼ 10 kPa) relative to compliant substrates, we
found a signiﬁcant increase in the expression of 151 genes
(Table S8) and a decrease of 57 genes (Table S9). A functional
analysis of astrocytes grown on stiff substrates showed, amongst
others, signiﬁcant increases in their inﬂammatory response
(P ¼ 1.5E-02), cell-mediated immune response (P ¼ 2.6E-03),
cellular growth and proliferation (P ¼ 5.1E-03), cell morphology
(P ¼ 5.8E-03), and cell-to-cell signaling and interaction (P ¼ 7.7E-
03) (Table S10; for signiﬁcant decreases see Table S11). Individual
genes that were enhanced on the stiffer substrates include in-
ﬂammatory proteins (CASP1), microtubule organizers (TUBE1,
MID1), molecular motors (KIF18B), extracellular matrix proteins
(FBN1, CSGALNACT1, HYAL3), cellecell adhesion proteins
(PCDHGB6), and growth and differentiation proteins (CCNF,
SMAD9, SEMA4C). In order to conﬁrm these mRNA changes, we
selected some key inﬂammation-related molecules, for which an-
tibodies exist, for examination at the protein level by immunocy-
tochemistry and Western blot. Astrocytes growing on stiff
substrates contained signiﬁcantly higher levels of pro-caspase-1
Fig. 4. In vivo FBR is triggered by the stiffness of an implant. (A) Schematic drawing of a composite foreign body (cFB) consisting of a compliant (G0 ¼ 100 Pa) and a stiff part
(G0 ¼ 30 kPa), both made from polyacrylamide. (B) Schematic coronal section and top view of a rat brain indicating the location of the cFB (dotted lines). The dashed gray line
indicates the region visible in (C), which shows brain tissue at the end of an experiment. Scale bar: 1 mm. (D) Immunohistochemistry of brain tissue in the vicinity of the compliant
and (E) stiff part of a cFB (asterisks) implanted for three weeks; blue: Hoechst stained nuclei, red: CD11b (OX 42) showing activated microglial cells, green: GFAP showing activated
astrocytes. Inﬂammatory and astrogliotic reactions are considerably increased around the stiff material (cf. Figs. S2, S3). Scale bar: 50 mm (F) A quantitative analysis of the ﬂuo-
rescence intensity of the brain tissue surrounding the cFB revealed that after one week the CD11b signal was signiﬁcantly increased around its stiff portion (P < 0.01; N ¼ 5; paired
one-tailed t-test; mean  S.E.M.), suggesting that more activated microglia were attracted towards the stiffer implant in the acute phase of the FBR. After three weeks, i.e., in the
chronic phase, GFAP as well as Interleukin 1b expression were also signiﬁcantly enhanced around the stiff part of the cFB (P < 0.05, N ¼ 5 and 3, respectively), indicating that
mechanical cues are involved in triggering gliotic and inﬂammatory reactions around foreign bodies, culminating in FBRs.
P. Moshayedi et al. / Biomaterials 35 (2014) 3919e3925 3923and pro-interleukin-1b (IL-1b) proteins (Fig. 3). IL-1b is considered
to be at the top of the hierarchy of the neuroinﬂammatory mediator
cascade [24].
3.4. In vivo experiments
The preceding results suggested that both astrocytes and
microglial cells change gene and protein expression as well as
morphology when grown on stiff materials compared to surfaceswith a compliance equivalent to that of brain tissue. These changes
on stiff substrates were characteristic of those seen in reactive
gliosis and FBR. We therefore devised an in vivo test and implanted
composite foreign bodies into rat brains to see whether gliosis and
the accompanying FBR can be triggered by mechanical cues. These
foreign bodies consisted of a compliant (G0 ¼ 100 Pa) and a stiff part
(G0 ¼ 30 kPa) made from the same material (polyacrylamide) as
used for the culture experiments. The grafts were left in place for
one or three weeks. We then performed immunohistochemistry on
P. Moshayedi et al. / Biomaterials 35 (2014) 3919e39253924sections of the tissue surrounding the implant, observing markers
of gliosis and inﬂammation (Fig. 4, S1eS3).
At oneweek, increased ﬂuorescence of CD11b (OX 42) revealed a
signiﬁcant increase in microglial activation around the stiff portion
of the foreign body if compared to its compliant region (P ¼ 0.008,
paired one-tailed t-test). GFAP levels in astrocytes were not
signiﬁcantly different in both regions (P ¼ 0.45). After three weeks,
however, reactive astrocytes surrounded the foreign body, with
signiﬁcantly higher GFAP levels around the stiff part of the implant
(P ¼ 0.02). Furthermore, IL-1b was signiﬁcantly upregulated in the
tissue in contact with the stiff part of the implants at that time point
(P ¼ 0.04) (Fig. 4EeG). Overall, three weeks after implantation cells
organized into a dense and distinct layer of tissue that encircled the
stiff portion of the implanted object.
4. Discussion
Our experiments show that both microglial cells and astrocytes,
the key contributors to FBR in CNS tissue, respond to mechanical
cues in vitro as well as in vivo in a way that is consistent with a
mechanical trigger of FBR. Contact with an unphysiologically stiff
surface causes bothmicroglia and astrocytes to display an acute and
late chronic inﬂammatory response typical for reactive gliosis. It is
possible that glial reactions tomechanical cues and/or distributions
of other cells which may contribute to glial scarring, such as peri-
cytes [25], are cortical layer-speciﬁc. However, when comparing
intensities of ﬂuorescent inﬂammation and astrogliosis markers
locally, and focusing on the tissue region where the soft and stiff
parts of the implant met, we found very similar differences as in the
global analysis shown in Fig. 4, indicating that our results are in-
dependent of the location within the cortex. Overall, our data
suggest a signiﬁcant contribution of glial cell mechanosensitivity to
triggering gliosis and FBR around implants in the CNS.
The stiffness of different tissues in our body spans several orders
of magnitude, from that of fat and brain tissue to that of bone and
teeth. Most if not all animal tissue cells, including glial cells and
neurons, are mechanosensitive and respond to mechanical stimuli
in their environment. Deviations from the physiological mechanical
properties of a tissue may accompany or even precede and/or
contribute to pathological changes [26e28]. It is important to note
that each type of tissue cell seems to have its own internal gauge for
a ‘normal’ stiffness; cells from stiffer tissues usually experience
larger stiffnesses as ‘normal’. Our current study promotes the thesis
that glial cells in the brain feel and respond to changes in the
stiffness of their environment and react by isolating the “foreign”,
stiff object from the surrounding physiologically soft tissue.
Cellular mechanosensitivity is increasingly recognized as an
important player in cell physiology and pathology. For example,
stem cell differentiation can be directed by mechanical cues [29],
towing by migrating cells can mechanically guide neuronal axon
pathﬁnding in vivo [30], and mechanical forces can even act as sec-
ond messenger in signal transduction [31]. While our data present
direct proof for an involvement of mechanical signaling at the onset
and during progression of FBR in the CNS, the molecular pathways
leading to the mechano-responsiveness of glial cells remain elusive
[17]. Our experiments reveal changes in the expression of many
genes in glial cells grown on stiff substrates (Tables S1, S8), which
could potentially be involved in their mechanosensitive response to
foreign bodies [14,17]. Further work will investigate molecular
mechanisms of glial cell mechanosensitivity.
5. Conclusions
FBR is a general phenomenon also found in other organ systems.
It is likely that macrophages as the ﬁrst line of defense in theseorgans will show similar responses to mechanical cues as do
microglia in the nervous system [32]. Hence, our data suggest that
adapting the surface mechanical properties of implants to the
physiological stiffness of the organ in which they are embedded
could signiﬁcantly alleviate FBR. Since most cell types probe their
substrate only a few tens of microns deep [33,34], a compliant
coating of appropriate thickness might be sufﬁcient to increase the
life time of electrodes implanted into brain tissue, and alleviate FBR
around other types of medical implants by improving their
biocompatibility. This improved implant design aspect could
signiﬁcantly improve the quality of life of many patients that
depend on long-term implant survival.
Acknowledgments
The authors would like to thank Stéphanie Lacour, Ivan Minev,
Krystyn Van Vliet, Robin Franklin, and Kate Hughes for inspiring
discussions and technical help. We would like to acknowledge
ﬁnancial support from the Cambridge Overseas Trust (ORS equiva-
lent bursary to PM), the UK Engineering and Physical Sciences
Research Council (Basic Technology Grant to PM, JWF, KF, JG), the
European Union FP7 programs EurOCHIP, Full4Health (GSHY), and
Angioscaff (JCFK), theMRC Centre for Obesity and RelatedMetabolic
Disorders (GSHY), the UK Biotechnology and Biological Sciences
Research Council (Research Development Fellowship to CEB), the
Christopher and Dana Reeves Foundation (JWF), the Human Fron-
tier Science Program (JG), the Marie Curie Initial Training Network
“Transpol” (GN, JG), the Alexander von Humboldt Foundation
(Feodor Lynen Fellowship toKF, AvHProfessorship to JG), and theUK
Medical Research Council (Career Development Award to KF).
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.biomaterials.2014.01.038.
References
[1] Polikov VS, Tresco PA, Reichert WM. Response of brain tissue to chronically
implanted neural electrodes. J Neurosci Methods 2005;148:1e18.
[2] Grill WM, Norman SE, Bellamkonda RV. Implanted neural interfaces: bio-
challenges and engineered solutions. Annu Rev Biomed Eng 2009;11:1e24.
[3] Tresco PA, Winslow BD. The challenge of integrating devices into the central
nervous system. Crit Rev Biomed Eng 2011;39:29e44.
[4] Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci
2004;5:146e56.
[5] Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005;50:
427e34.
[6] He W, Bellamkonda RV. A molecular perspective on understanding and
modulating the performance of chronic central nervous system (CNS)
recording electrodes. In: Reichert WM, editor. Indwelling neural implants:
strategies for contending with the in vivo environment. Boca Raton (FL): CRC
Press; 2008.
[7] Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia.
Physiol Rev 2011;91:461e553.
[8] Popovich PG, Wei P, Stokes BT. Cellular inﬂammatory response after spinal
cord injury in SpragueeDawley and Lewis rats. J Comp Neurol 1997;377:
443e64.
[9] He W, McConnell GC, Bellamkonda RV. Nanoscale laminin coating modulates
cortical scarring response around implanted silicon microelectrode arrays.
J Neural Eng 2006;3:316e26.
[10] Bryers JD, Giachelli CM, Ratner BD. Engineering biomaterials to integrate and
heal: the biocompatibility paradigm shifts. Biotechnol Bioeng 2012;109:
1898e911.
[11] Flanagan LA, Ju YE, Marg B, Osterﬁeld M, Janmey PA. Neurite branching on
deformable substrates. Neuroreport 2002;13:2411e5.
[12] Georges PC, Miller WJ, Meaney DF, Sawyer ES, Janmey PA. Matrices with
compliance comparable to that of brain tissue select neuronal over glial
growth in mixed cortical cultures. Biophys J 2006;90:3012e8.
[13] Moshayedi P, Costa LD, Christ A, Lacour SP, Fawcett J, Guck J, et al. Mecha-
nosensitivity of astrocytes on optimized polyacrylamide gels analyzed by
quantitative morphometry. J Phys Condens Matter 2010;22. http://dx.doi.org/
10.1088/0953-8984/22/19/194114.
P. Moshayedi et al. / Biomaterials 35 (2014) 3919e3925 3925[14] Franze K, Guck J. The biophysics of neuronal growth. Rep Prog Phys 2010;73.
http://dx.doi.org/10.1088/0034-4885/73/9/094601.
[15] Franze K. Atomic force microscopy and its contribution to understanding the
development of the nervous system. Curr Opin Genet Dev 2011;21:530e7.
[16] Jagielska A, Norman AL, Whyte G, Vliet KJ, Guck J, Franklin RJ. Mechanical
environment modulates biological properties of oligodendrocyte progenitor
cells. Stem Cells Dev 2012;21:2905e14.
[17] Franze K, Janmey PA, Guck J. Mechanics in neuronal development and repair.
Annu Rev Biomed Eng 2013;15:227e51.
[18] Wilby MJ, Muir EM, Fok-Seang J, Gour BJ, Blaschuk OW, Fawcett JW. N-Cad-
herin inhibits Schwann cell migration on astrocytes. Mol Cell Neurosci
1999;14:66e84.
[19] Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al.
Exploration, normalization, and summaries of high density oligonucleotide
array probe level data. Biostatistics 2003;4:249e64.
[20] Binder H, Preibisch S, Berger H. Calibration of microarray gene-expression
data. Methods Mol Biol 2010;576:375e407.
[21] Christ AF, Franze K, Gautier H, Moshayedi P, Fawcett J, Franklin RJ, et al.
Mechanical difference between white and gray matter in the rat cerebellum
measured by scanning force microscopy. J Biomech 2010;43:2986e92.
[22] Lu YB, Franze K, Seifert G, Steinhauser C, Kirchhoff F, Wolburg H, et al.
Viscoelastic properties of individual glial cells and neurons in the CNS. Proc
Natl Acad Sci U S A 2006;103:17759e64.
[23] Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends
Neurosci 1996;19:312e8.
[24] Basu A, Krady JK, Levison SW. Interleukin-1: a master regulator of neuro-
inﬂammation. J Neurosci Res 2004;78:151e6.[25] Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisen J. A pericyte
origin of spinal cord scar tissue. Science 2011;333:238e42.
[26] Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, et al.
Increased stiffness of the rat liver precedes matrix deposition: implications for
ﬁbrosis. Am J Physiol Gastrointest Liver Physiol 2007;293:G1147e54.
[27] Zhao G, Cui J, Qin Q, Zhang J, Liu L, Deng S, et al. Mechanical stiffness of liver
tissues in relation to integrin beta1 expression may inﬂuence the develop-
ment of hepatic cirrhosis and hepatocellular carcinoma. J Surg Oncol
2010;102:482e9.
[28] Glasser SP. On arterial physiology, pathophysiology of vascular compliance,
and cardiovascular disease. Heart Dis 2000;2:375e9.
[29] Engler AJ, Sweeney HL, Discher DE, Schwarzbauer JE. Extracellular matrix
elasticity directs stem cell differentiation. J Musculoskelet Neuronal Interact
2007;7:335.
[30] Gilmour D, Knaut H, Maischein HM, Nusslein-Volhard C. Towing of sensory
axons by their migrating target cells in vivo. Nat Neurosci 2004;7:491e2.
[31] Hardie RC, Franze K. Photomechanical responses in Drosophila photorecep-
tors. Science 2012;338:260e3.
[32] Blakney AK, Swartzlander MD, Bryant SJ. The effects of substrate stiffness on
the in vitro activation of macrophages and in vivo host response to poly(-
ethylene glycol)-based hydrogels. J Biomed Mater Res A 2012;100:1375e86.
[33] Buxboim A, Rajagopal K, Brown AE, Discher DE. How deeply cells feel:
methods for thin gels. J Phys Condens Matter 2010;22:194116.
[34] Kuo CH, Xian J, Brenton JD, Franze K, Sivaniah E. Complex stiffness gradient
substrates for studying mechanotactic cell migration. Adv Mater 2012;24:
6059e64.
